Methylphenidate may enhance oculomotor function in individuals with multiple sclerosis

FHS
June 26, 2024
6:54 pm

A pilot study conducted by Kessler Foundation researchers has shown promising results in the use of methylphenidate to enhance oculomotor function in individuals with multiple sclerosis (MS).

Diabetes management program cuts dementia risk in type 2 patients

A recent study highlights the effectiveness of a multidisciplinary diabetes management program in reducing the risk of dementia in type 2 diabetes patients, emphasizing the

February 14, 2024

FDA finalizes combination product guidance 7 years after sharing draft

Dive Brief: The Food and Drug Administration has finalized its guidance on the application of human factors engineering principles to combination products. Officials released a

September 13, 2023

How do sex hormones and birth control affect brain fear circuits?

Researchers explores how oral contraceptive pill use interacts with the current hormonal status to affect the fear circuit structure within the brain.

November 9, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.